VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $4,299,000 | -17.2% | 300,000 | 0.0% | 0.35% | -18.8% |
| Q2 2017 | $5,190,000 | +20.6% | 300,000 | -23.1% | 0.43% | -22.8% |
| Q1 2017 | $4,302,000 | -45.9% | 390,000 | +875.0% | 0.56% | +6.7% |
| Q1 2015 | $7,945,000 | -38.3% | 40,000 | -55.6% | 0.52% | -30.4% |
| Q4 2014 | $12,880,000 | +9.1% | 90,000 | 0.0% | 0.75% | +48.5% |
| Q3 2014 | $11,808,000 | +4.0% | 90,000 | 0.0% | 0.50% | +26.9% |
| Q2 2014 | $11,351,000 | – | 90,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |